# Evolent

> Evolent is an Arlington, Virginia-based health company that helps insurers and providers manage the cost and quality of expensive specialty care - cancer, heart disease, and musculoskeletal conditions. Instead of the traditional 'deny the claim' model, Evolent pairs clinical pathways, its own doctors and nurses, and a technology platform called Identifi to steer treatment toward evidence-based decisions, taking on financial risk for the outcomes. Founded in 2011 and public since 2015 (NYSE: EVH), it covers roughly 40 million members across the United States.

- **Founded:** 2011
- **Headquarters:** Arlington, Virginia, United States
- **Founders:** Frank Williams (Co-founder, former Chairman & CEO), Seth Blackley (Co-founder & CEO), Tom Peterson (Co-founder)
- **Team size:** ~4,000-4,200 employees, including more than 1,300 clinicians (roughly 400 physicians and 750 nurses).
- **Products:** Oncology (Specialty Care Management), Cardiology, Musculoskeletal, Radiology & Advanced Imaging, Genetic Testing Management
- **Notable:** Grew from a 2011 joint venture to a NYSE-listed company (IPO 2015) surpassing $2 billion in annual revenue., Covers roughly 40 million unique members across the United States., Unified four legacy brands (New Century Health, NIA, IPG, Vital Decisions) into a single Evolent organization in 2023.

## Products & services

- **Oncology (Specialty Care Management)** — Evidence-based clinical pathways, oncology decision support, provider engagement, and cancer care navigation to improve adherence and manage the total cost of cancer care.
- **Cardiology** — Cardiovascular care management combining clinical pathways, prior authorization, and provider collaboration to align treatment with clinical evidence.
- **Musculoskeletal** — Management of orthopedics, spine, physical medicine, and pain, aimed at reducing avoidable surgery and steering high-value care (legacy NIA/IPG capabilities).
- **Radiology & Advanced Imaging** — Utilization management and imaging safety for advanced diagnostic imaging.
- **Genetic Testing Management** — Oversight of the fast-growing and often unmanaged category of genetic and molecular testing.
- **Identifi Platform** — Evolent's proprietary technology platform that integrates clinical data, analytics, pathways, and workflow to power its specialty care programs.
- **Administrative Services** — Utilization management, quality reporting, and care coordination services for health plans.

## Achievements

- Grew from a 2011 joint venture to a NYSE-listed company (IPO 2015) surpassing $2 billion in annual revenue.
- Covers roughly 40 million unique members across the United States.
- Unified four legacy brands (New Century Health, NIA, IPG, Vital Decisions) into a single Evolent organization in 2023.
- Reports typical 30%+ increases in adherence to evidence-based clinical pathways in its specialty programs.
- Employs more than 1,300 clinicians, including ~400 physicians and ~750 nurses.

## Latest updates

- **2025-11** — Reported third-quarter 2025 results, citing continued specialty care growth, profitability and cash flow.
- **2025-09** — Agreed to sell its value-based primary care business, Evolent Care Partners, to Privia Health for up to $113 million to focus on specialty care.
- **2026-08** — Reported second-quarter 2026 results; CEO Seth Blackley pointed to strong growth, profitability and cash flow.

## Links

- Website: https://www.evolent.com
- LinkedIn: https://www.linkedin.com/company/evolent
- Twitter/X: https://twitter.com/evolenthealth

---

Profile page: https://yespress.io/evolent
Published by YesPress — https://yespress.io
Last updated: 2026-08-12